Creating a foundation for personalized age- and sex-based immune-targeted therapies from an ALS longitudinal cohort by identifying peripheral and central immune signatures
通过识别外周和中枢免疫特征,为 ALS 纵向队列中基于年龄和性别的个性化免疫靶向治疗奠定基础
基本信息
- 批准号:10403433
- 负责人:
- 金额:$ 63.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-15 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:ALS patientsAddressAffectAgeAmyotrophic Lateral SclerosisAnimalsAreaBiological MarkersBloodBlood specimenCD4 Positive T LymphocytesCell CountCellsCessation of lifeCharacteristicsClinicalClinical TrialsCoculture TechniquesDataData SetDevelopmentDiseaseDisease ProgressionEstrogensFoundationsGoalsGonadal Steroid HormonesHormonesHumanImmuneImmune TargetingImmune responseImmune systemImmunomodulatorsImmunophenotypingIn VitroIndividualInduced pluripotent stem cell derived neuronsInflammationInflammatoryKnowledgeLinkLiteratureLongitudinal StudiesLongitudinal cohortMediatingMichiganMissionMotor Neuron DiseaseNatural Killer CellsNervous system structureNeuronsOutcomePathway interactionsPatientsPeripheralPersonsPhenotypePopulationPositron-Emission TomographyProstitutionPublic HealthRecording of previous eventsRegulatory T-LymphocyteResearchSamplingSeverity of illnessSurvival RateSystemTestosteroneTimeToxic effectTweensUnited States National Institutes of HealthUniversitiesamyotrophic lateral sclerosis therapybasebiobankcohortcytotoxicitydeep neural networkdesigndrug developmentdrug repurposingeffective therapyimmune functionin vivoinnovationinsightinterestknowledge basenervous system disorderneuroinflammationneurotoxicityneutrophilnew therapeutic targetperipheral bloodpersonalized medicinepersonalized therapeuticpredictive modelingsextargeted treatmenttherapeutic developmenttherapeutic targettranscriptome sequencing
项目摘要
ABSTRACT
The immune system contributes to amyotrophic lateral sclerosis (ALS) progression and survival, and therapies
to target the immune system are of burgeoning interest. However, the changes in the immune system during
the course of ALS and the sex-specific alterations in immune function warrant a more in depth analysis in order
to develop personalized ALS therapies and biomarkers. The long-term goals are to harness the immune sys-
tem’s potential to slow and stop the progression of ALS. The overall objective is to determine how peripheral
immune profiles, sex, age, and sex hormones, link to neuronal damage, neuroinflammation, and ALS progres-
sion and survival. The central hypothesis is that peripheral immune profiles are an important pathophysiologic
agent of ALS progression and survival; that sex, age and sex hormone levels impact these profiles; and that
insight into ALS patient-specific immune profiles will yield new drug targets and therapeutic windows. Our ra-
tionale is that linking patient-specific immune cell profiles to ALS progression and survival will facilitate person-
alized immunomodulatory therapeutic development for ALS and identify potential treatment windows. The cen-
tral hypothesis will be pursued with three aims: 1) Identify specific immune profiles that associate with ALS pro-
gression and survival rates.; 2) Evaluate the effects of sex hormones on ALS immune profiles, progression,
and survival; and 3) Identify immune profiles and corresponding cellular pathways that are most toxic to neu-
rons and that associate with central inflammation. In Aim 1 longitudinal immunophenotyping of peripheral blood
samples from ALS subjects will generate composite immune profiles that will then be linked to ALS subject
characteristics, progression, and survival. Aim 2 will determine if observed sex-dependent associations be-
tween immune profiles and ALS progression and survival are mediated by sex hormones, as sex hormones
can alter immune profiles. Aim 3 will enrich a cohort of ALS subjects by immune profile clusters; their periph-
eral immune populations will be analyzed using 1) RNA-seq and 2) cell toxicity studies via co-cultures with
iPSC-derived neurons; subjects will also have positron emission tomography (PET) imaging to quantify central
neuroinflammation. Datasets will be synthesized to build prediction models and create deep neural networks
capable of associating immune profiles with sex, age, disease severity, progression, and survival The research
proposed is innovative, in the applicants’ opinion, because it rigorously examines the effects of sex, age, and
sex hormone levels on immune cells and ALS progression and survival in a longitudinal study. It also accounts
for the interactions between immune cells by forming immune profiles for individual subjects and assesses how
specific profiles associate with dysregulated pathways, cytotoxicity, and neuroinflammation. The proposed re-
search is significant because it will provide critical data on the distinct immune profiles and pathways associ-
ated with ALS progression and survival in a sex-, age- and sex hormone- specific fashion.
抽象的
免疫系统有助于肌萎缩性侧面硬化症(ALS)进展和生存,疗法
靶向免疫系统具有野蛮的兴趣。但是,免疫系统的变化
ALS的过程和免疫功能的性别特异性改变需要更深入的分析
开发个性化的ALS疗法和生物标志物。长期目标是利用免疫系统 -
TEM有可能减慢和阻止ALS的进展。总体目标是确定外围
免疫特征,性别,年龄和性马,与神经元损害,神经炎症的联系,ALS的进展 -
sion和生存。中心假设是外周免疫特征是重要的病理生理学
ALS进展和生存的代理;性别,年龄和性激素水平会影响这些特征。那
洞悉ALS患者特异性免疫特征将产生新的药物靶标和治疗窗口。我们的ra-
tionale是,将患者特异性免疫元素与ALS的进展和生存联系起来将有助于人 -
ALS的二聚体免疫调节热发育并确定潜在的治疗窗口。 cen-
TRAL假设将以三个目的进行:1)确定与ALS促进的特定免疫特征
问候和生存率。 2)评估性恐怖对ALS免疫特征,进展,
和生存; 3)确定对Neu-最具毒性的免疫特征和相应的细胞途径
罗恩斯和那个与中央感染有关的。在AIM 1外周血的纵向免疫结构
来自ALS受试者的样本将产生复合免疫特征,然后将其链接到ALS受试者
特征,发展和生存。 AIM 2将确定观察到的性别依赖性关联是否是
推文免疫特征,ALS的进展和生存是由性激素介导的,作为性激素
可以改变免疫特征。 AIM 3将通过免疫轮廓簇丰富一群ALS受试者。他们的外围
将使用1)RNA-seq和2)通过与共同培养的细胞毒性研究对ERA免疫筛查进行分析
IPSC衍生的神经元;受试者还将具有正电子发射断层扫描(PET)成像以量化中央
神经炎症。数据集将被合成以构建预测模型并创建深层神经元网络
能够将免疫特征与性别,年龄,疾病严重程度,进展和生存相关联
申请人认为,拟议的是创新的,因为它严格研究了性,年龄和
在一项纵向研究中,免疫细胞和ALS进展和存活的性骑士水平。它也是帐户
对于免疫细胞之间的相互作用,通过形成单个受试者的免疫特征和评估如何
与途径失调,细胞毒性和神经炎症相关的特定轮廓。拟议的重新
搜索很重要,因为它将提供有关独特的免疫特征和关联途径的关键数据
在性别,年龄和性激素特定的时尚中以ALS的进展和生存为生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen Goutman其他文献
Stephen Goutman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen Goutman', 18)}}的其他基金
Creating a foundation for personalized age- and sex-based immune-targeted therapies from an ALS longitudinal cohort by identifying peripheral and central immune signatures
通过识别外周和中枢免疫特征,为 ALS 纵向队列中基于年龄和性别的个性化免疫靶向治疗奠定基础
- 批准号:
10177640 - 财政年份:2021
- 资助金额:
$ 63.37万 - 项目类别:
Creating a foundation for personalized age- and sex-based immune-targeted therapies from an ALS longitudinal cohort by identifying peripheral and central immune signatures
通过识别外周和中枢免疫特征,为 ALS 纵向队列中基于年龄和性别的个性化免疫靶向治疗奠定基础
- 批准号:
10570968 - 财政年份:2021
- 资助金额:
$ 63.37万 - 项目类别:
Impact of Geospatial Factors and Environmental Pollutants on Amyotrophic Lateral Sclerosis in the State of Michigan
地理空间因素和环境污染物对密歇根州肌萎缩侧索硬化症的影响
- 批准号:
9312942 - 财政年份:2017
- 资助金额:
$ 63.37万 - 项目类别:
Impact of Geospatial Factors and Environmental Pollutants on Amyotrophic Lateral Sclerosis in the State of Michigan
地理空间因素和环境污染物对密歇根州肌萎缩侧索硬化症的影响
- 批准号:
10163055 - 财政年份:2017
- 资助金额:
$ 63.37万 - 项目类别:
Impact of Geospatial Factors and Environmental Pollutants on Amyotrophic Lateral Sclerosis in the State of Michigan
地理空间因素和环境污染物对密歇根州肌萎缩侧索硬化症的影响
- 批准号:
9912765 - 财政年份:2017
- 资助金额:
$ 63.37万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Delineating the functional impact of recurrent repeat expansions in ALS using integrative multiomic analysis
使用综合多组学分析描述 ALS 中反复重复扩增的功能影响
- 批准号:
10776994 - 财政年份:2023
- 资助金额:
$ 63.37万 - 项目类别:
Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).
CNM-Au8 在肌萎缩侧索硬化症 (ALS) 中的中等规模扩展访问协议。
- 批准号:
10835565 - 财政年份:2023
- 资助金额:
$ 63.37万 - 项目类别:
Development of a SYF2 antisense oligonucleotide treatment for ALS and FTD
开发治疗 ALS 和 FTD 的 SYF2 反义寡核苷酸
- 批准号:
10547625 - 财政年份:2023
- 资助金额:
$ 63.37万 - 项目类别:
Investigating the Role of MS4As in Amyotrophic Lateral Sclerosis
研究 MS4As 在肌萎缩侧索硬化症中的作用
- 批准号:
10751695 - 财政年份:2023
- 资助金额:
$ 63.37万 - 项目类别: